Capital Asset Advisory Services LLC bought a new stake in shares of Danaher Co. (NYSE:DHR) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 653 shares of the conglomerate’s stock, valued at approximately $145,000.
Several other hedge funds have also added to or reduced their stakes in DHR. Edgewood Management LLC lifted its holdings in shares of Danaher by 109.5% during the fourth quarter. Edgewood Management LLC now owns 8,359,799 shares of the conglomerate’s stock valued at $1,857,046,000 after purchasing an additional 4,368,967 shares during the last quarter. BlackRock Inc. lifted its holdings in shares of Danaher by 3.7% during the fourth quarter. BlackRock Inc. now owns 45,709,313 shares of the conglomerate’s stock valued at $10,153,866,000 after purchasing an additional 1,646,434 shares during the last quarter. D1 Capital Partners L.P. raised its holdings in Danaher by 88.2% in the 4th quarter. D1 Capital Partners L.P. now owns 2,582,346 shares of the conglomerate’s stock worth $573,642,000 after acquiring an additional 1,210,565 shares during the last quarter. FMR LLC raised its holdings in Danaher by 3.7% in the 4th quarter. FMR LLC now owns 31,141,354 shares of the conglomerate’s stock worth $6,917,740,000 after acquiring an additional 1,103,795 shares during the last quarter. Finally, Renaissance Technologies LLC raised its holdings in Danaher by 562.3% in the 4th quarter. Renaissance Technologies LLC now owns 997,736 shares of the conglomerate’s stock worth $221,637,000 after acquiring an additional 847,100 shares during the last quarter. Hedge funds and other institutional investors own 78.00% of the company’s stock.
In other news, SVP Angela S. Lalor sold 6,437 shares of the business’s stock in a transaction on Friday, February 12th. The shares were sold at an average price of $244.70, for a total transaction of $1,575,133.90. Following the completion of the sale, the senior vice president now owns 25,148 shares of the company’s stock, valued at approximately $6,153,715.60. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 11.70% of the company’s stock.
Shares of DHR opened at $226.07 on Thursday. The firm has a market cap of $161.20 billion, a PE ratio of 45.76, a P/E/G ratio of 1.92 and a beta of 0.72. The company has a current ratio of 2.08, a quick ratio of 1.68 and a debt-to-equity ratio of 0.63. The firm has a fifty day simple moving average of $222.47 and a two-hundred day simple moving average of $226.76. Danaher Co. has a 1-year low of $138.07 and a 1-year high of $248.86.
Danaher (NYSE:DHR) last issued its quarterly earnings data on Thursday, January 28th. The conglomerate reported $2.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.84 by $0.24. Danaher had a net margin of 18.05% and a return on equity of 12.94%. The firm had revenue of $6.76 billion during the quarter, compared to the consensus estimate of $6.62 billion. During the same quarter in the previous year, the firm posted $1.28 EPS. The company’s revenue for the quarter was up 38.9% compared to the same quarter last year. As a group, research analysts forecast that Danaher Co. will post 6.05 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 30th. Stockholders of record on Friday, March 26th will be given a dividend of $0.21 per share. This is an increase from Danaher’s previous quarterly dividend of $0.18. The ex-dividend date is Thursday, March 25th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.37%. Danaher’s payout ratio is presently 19.00%.
A number of brokerages recently weighed in on DHR. Zacks Investment Research lowered shares of Danaher from a “buy” rating to a “hold” rating and set a $228.00 price objective for the company. in a report on Tuesday, March 16th. Credit Suisse Group boosted their price objective on shares of Danaher from $260.00 to $264.00 and gave the stock an “outperform” rating in a report on Thursday, January 14th. Finally, Barclays began coverage on shares of Danaher in a report on Monday, March 8th. They issued an “overweight” rating and a $260.00 price objective for the company. Three investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $236.47.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Further Reading: What is Compound Annual Growth Rate (CAGR)?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.